Subscribe
We profile resilient American companies that can add oomph to a portfolio no matter what type of investor you are
Quality US Shares 2023: Weight-loss drug fears look overblown while the confectioner's sales and margins are protected
Quality US Shares 2023: The former Pfizer-owned brand has sector-leading margins and knows people think of pets as family
Quality US Shares 2023: Sales and operating profit have grown at a compound rate of 10 per cent over the past five years
The Investors' Chronicle Investment Trust Special Report 2023
Pack your bags, buccaneering investor: we鈥檙e off once more on a globe-spanning pursuit of investment riches
All businesses want to grow sales, customers and market share. But trying too much too soon can cost investors
Lessons from History: Few will mark the 15th anniversary with any enthusiasm, but with regulatory reforms in the offing, what has been learned?
Britain is no worse than others at building infrastructure, but there鈥檚 much to be done to ensure projects deliver for taxpayers, users and investors. Michael Fahy reports
Our review of the 100 biggest companies on Aim gives you an insight into whether these businesses can boost your portfolio
